Authors
Latest:
Clinical Overview: Updates in Pharmacologic Options for the Treatment of Schizophrenia, Bipolar DisorderThe ease of administration with new agents for schizophrenia via an injection is advantageous because this patient population is commonly agitated and difficult to administer oral medications to.
Latest:
Oncology Overview: Treatment of Chronic Lymphocytic Leukemia with Ibrutinib, VenetoclaxBoth ibrutinib (Imbruvica) and venetoclax (Venclexta) carry an approved indication for use in chronic lymphocytic leukemia but do not often lead to complete remission, and therapy routinely continues indefinitely or until disease progression.
Latest:
New Tool Helps Providers Navigate Adalimumab BiosimilarsThe tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.
Latest:
Clearing the Air: The Influence of Vaping on Smoking CessationPharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.
Latest:
Preparing for Success: Tips on How to Excel on Your IPPE RotationsFive tips to keep in mind before you begin your IPPEs.
Latest:
Staff Pharmacists Discuss Updated Carboplatin Drug Shortage Mitigation Strategies at the University of Illinois at Chicago Oncology Clinic PharmacyAfter carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.
Latest:
Interactive Case Studies- February 2023Cases discuss patients with medication allergies and drug interactions.
Latest:
Our Shot to Stop the Pandemic: A Student's PerspectivePharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.
Latest:
New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell LymphomaThe FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma.
Latest:
Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy ProgramPharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Latest:
Exploring the Benefits, Risks, and Clinical Implications of Herbal SupplementsExamining the clinical applications, effectiveness, safety, and regulation of herbal supplements with a focus on the role of pharmacists.
Latest:
Tip of the Week: Staying Ahead of Change to Maintain a Healthy Work EnvironmentThere are a number of ways in which job design and working conditions can be improved in the community pharmacy setting, either on the store level or on an organization-wide basis.
Latest:
Five Steps to Ensure Accurate 340B Program DataHospitals and health systems proactively monitor and manage data accuracy with third-party administrators to maintain 340B program compliance and maximize benefits for vulnerable patient populations.
Latest:
The Blood Detective: Tackling Medication-Induced Hematological DisordersThese disorders can be fatal, making pharmacists’ role in detection crucial.
Latest:
Experts Highlight RSV Vaccination Strategies: Maternal Immunization, Infant Protection, and Clinical Considerations for 2025RSV vaccines for pregnant women and infants require careful timing and administration.
Latest:
Integrating Pharmacists Into Care Teams Is CrucialTapping their specific skill sets and training can help serve patients more effectively, although challenges exist.
Latest:
The Impact of Xylazine on Overdose ResponsePharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.
Latest:
Business Solutions Drive Meaningful Results for PharmaciesAs pharmacists provide more health care services, opportunities arise for more sophisticated patient engagement and billing solutions that drive patient satisfaction and increased loyalty.
Latest:
Temelimab: A Novel Disease-Modifying Agent for Diabetes ManagementTemelimab is a recombinant humanized IgG4 monoclonal antibody that blocks the HERV-W protein, which is associated with the pathology of autoimmune disorders, such as multiple sclerosis and type 1 diabetes.
Latest:
Additional Considerations With PBC TherapiesPanelists discuss how recent FDA regulatory actions regarding obeticholic acid have raised concerns about its long-term safety profile and accessibility, leading health care teams to develop strategies for supporting patients through treatment transitions while navigating insurance coverage and access challenges for newer primary biliary cholangitis (PBC) therapies.
Latest:
Despite Demonstrated Efficacy, The Future of Antiobesity Medications Depends Largely On SupplyPricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.
Latest:
Celebrating Unique Pharmacist Career Paths That Drive InnovationOn the heels of Women Pharmacist Day on October 12, we highlight 3 female pharmacists who have followed unique career paths that help to drive innovation and change in the industry, beyond the retail pharmacy setting.
Latest:
Lifestyle Medicine Presents Unexpected Opportunity for PharmacistsPharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.
Latest:
Movement Scores and Beyond: Patient-Reported Outcomes in Tardive Dyskinesia ManagementPanelists discuss how the use of both clinician- and patient-reported scales—such as the Impact TD scale, TDIS, and Impact TD Pro—enhances understanding of tardive dyskinesia’s true impact on daily functioning and quality of life, emphasizing the importance of incorporating patient perspectives to guide early, personalized treatment strategies that improve physical symptoms and overall well-being.
Latest:
Pharmacists as Advocates: How the MIP Model Supports Access, Adherence, and OutcomesMedically integrated pharmacies improve collaboration, patient care, communication, and therapy management.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
New Therapy for Chronic Graft-Vs-Host Disease: AxatilimabAxatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.
Latest:
How Pharmacists Can Make an Impact When Treating Dedifferentiated Liposarcoma With BrigimadlinBrigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.
Latest:
Breaking Down Barriers to Care and Transforming Pharmacy Professionals’ Mental HealthPharmacy professionals deserve the right to pursue mental health care without fear of losing their jobs. The Wellbeing First Champion Challenge is helping change this.
